IN2014DN09940A - - Google Patents
Info
- Publication number
- IN2014DN09940A IN2014DN09940A IN9940DEN2014A IN2014DN09940A IN 2014DN09940 A IN2014DN09940 A IN 2014DN09940A IN 9940DEN2014 A IN9940DEN2014 A IN 9940DEN2014A IN 2014DN09940 A IN2014DN09940 A IN 2014DN09940A
- Authority
- IN
- India
- Prior art keywords
- melatonin
- field
- memantine
- capsules
- pharmaceutical
- Prior art date
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 2
- 229960003987 melatonin Drugs 0.000 abstract 2
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 abstract 2
- 229960004640 memantine Drugs 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012121410/15A RU2488388C1 (ru) | 2012-05-24 | 2012-05-24 | Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств |
| PCT/RU2012/000888 WO2013176567A1 (ru) | 2012-05-24 | 2012-10-31 | Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09940A true IN2014DN09940A (enEXAMPLES) | 2015-08-14 |
Family
ID=49155569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9940DEN2014 IN2014DN09940A (enEXAMPLES) | 2012-05-24 | 2012-10-31 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20150157604A1 (enEXAMPLES) |
| EP (1) | EP2857011A4 (enEXAMPLES) |
| JP (1) | JP5864819B2 (enEXAMPLES) |
| KR (1) | KR101581611B1 (enEXAMPLES) |
| CN (1) | CN104334166A (enEXAMPLES) |
| AU (1) | AU2012380583B2 (enEXAMPLES) |
| CA (1) | CA2873891C (enEXAMPLES) |
| EA (1) | EA201400973A1 (enEXAMPLES) |
| HK (1) | HK1205467A1 (enEXAMPLES) |
| IL (1) | IL235852A0 (enEXAMPLES) |
| IN (1) | IN2014DN09940A (enEXAMPLES) |
| RU (1) | RU2488388C1 (enEXAMPLES) |
| UA (1) | UA112352C2 (enEXAMPLES) |
| WO (1) | WO2013176567A1 (enEXAMPLES) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2536270C1 (ru) * | 2013-10-21 | 2014-12-20 | Общество с ограниченной ответственностью ООО "ВАЛЕНТА ИНТЕЛЛЕКТ" | Комбинация для коррекции неврологического и психоэмоционального статуса при органических нарушениях цнс |
| IL295071A (en) | 2015-11-24 | 2022-09-01 | Massachusetts Inst Technology | Systems and methods for preventing, mitigating, and/or treating dementia |
| IL263976B2 (en) * | 2016-06-29 | 2023-09-01 | Valenta Intellekt Ltd | Preparations containing memantin and melatonin |
| RU2654713C1 (ru) * | 2016-06-29 | 2018-05-22 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, содержащая комбинацию мемантина и мелатонина |
| RU2623865C1 (ru) * | 2016-06-29 | 2017-06-29 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, содержащая комбинацию мемантина и мелатонина |
| US10849856B2 (en) | 2016-10-31 | 2020-12-01 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
| LT3777842T (lt) | 2016-10-31 | 2025-04-10 | Neurim Pharmaceuticals Ltd. | Melatonino mini tabletės ir jų gamybos būdas |
| WO2018094232A1 (en) | 2016-11-17 | 2018-05-24 | Cognito Therapeutics, Inc. | Methods and systems for neural stimulation via visual, auditory and peripheral nerve stimulations |
| CA3078704A1 (en) | 2017-10-10 | 2019-04-18 | Massachusetts Institute Of Technology | Systems and methods for preventing, mitigating, and/or treating dementia |
| US10960225B2 (en) * | 2017-10-10 | 2021-03-30 | Massachusetts Institute Of Technology | Systems and methods for preventing, mitigating, and/or treating dementia via visual stimulation that binds higher order brain regions, reduces neurodegeneration and neuroinflammation, and improves cognitive function |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7305644A (enEXAMPLES) | 1972-04-20 | 1973-10-23 | ||
| DE2856393C2 (de) | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
| EP0392059B1 (de) | 1989-04-14 | 1993-09-15 | Merz & Co. GmbH & Co. | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie |
| US5614560A (en) | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
| US6469044B1 (en) | 1995-02-01 | 2002-10-22 | Neurim Pharmaceuticals (1991) Ltd. | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| IL133235A (en) * | 1997-06-30 | 2004-02-19 | Merz Pharma Gmbh & Co Kgaa | 1-amino-alkylcyclohexane nmda receptor antagonists and pharmaceutical compositions comprising them |
| US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
| US20050129783A1 (en) * | 2001-04-19 | 2005-06-16 | Mccleary Edward L. | Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health |
| US7183321B2 (en) * | 2001-12-17 | 2007-02-27 | Bristol-Myers Squibb Company | Antidiabetic formulation and method |
| DK1562585T3 (da) | 2002-10-30 | 2011-03-14 | Asat Ag Applied Science & Tech | Daglige melatonindoseringsenheder |
| RU2268737C2 (ru) | 2004-02-16 | 2006-01-27 | Государственное учреждение институт клинической иммунологии СО РАМН | Способ лечения атопического дерматита |
| WO2006009769A1 (en) * | 2004-06-17 | 2006-01-26 | Forest Laboratories, Inc. | Modified release formulation of memantine |
| EP1841460A2 (en) * | 2004-06-18 | 2007-10-10 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| CA2578953A1 (en) * | 2004-09-23 | 2006-03-30 | Merz Pharma Gmbh & Co. Kgaa | Memantine for the treatment of childhood behavioral disorders |
| MY148806A (en) * | 2005-04-04 | 2013-05-31 | Takeda Pharmaceutical | Prophylactic or therapeutic agent for nocturnal conduct disorder associated with dementia |
| CN1709230A (zh) * | 2005-07-05 | 2005-12-21 | 北京阜康仁生物制药科技有限公司 | 盐酸美金刚分散片及其制备方法 |
| RU2294741C1 (ru) | 2005-08-08 | 2007-03-10 | Рина Михайловна Заславская | Способ лечения больных ишемической болезнью сердца, стабильной стенокардией в сочетании с артериальной гипертонией |
| CA2652421A1 (en) * | 2006-05-22 | 2007-11-29 | Vanda Pharmaceuticals, Inc. | Treatment for depressive disorders |
| BRPI0711872A2 (pt) * | 2006-05-22 | 2011-12-06 | Vanda Pharmaceuticals Inc | tratamento para distúrbios depressivos |
| JP2009542647A (ja) * | 2006-07-05 | 2009-12-03 | テバ ファーマシューティカル インダストリーズ リミティド | メマンチン医薬組成物 |
| US20080008743A1 (en) * | 2006-07-06 | 2008-01-10 | Forest Laboratories Holdings Limited | Orally Dissolving Formulations of Memantine |
| GB0623897D0 (en) * | 2006-11-30 | 2007-01-10 | Pliva Istrazivanje I Razvoj D | Pharmaceutical composition of memantine |
| WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
| RU2326660C1 (ru) | 2007-03-14 | 2008-06-20 | Закрытое акционерное общество "Биологические исследования и системы" | Пероральный лекарственный препарат мемантин (варианты) и способ его получения (варианты) |
| JP5600058B2 (ja) | 2007-04-11 | 2014-10-01 | ファーマシューティカル プロダクションズ， インコーポレイテッド | メラトニンタブレットならびに調剤及び使用方法 |
| AU2008240211A1 (en) | 2007-04-12 | 2008-10-23 | Regents Of The University Of Minnesota | Ischemia/reperfusion protection compositions and methods of using |
| US20100256184A1 (en) * | 2008-08-13 | 2010-10-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| AU2010211220B2 (en) * | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
| RU2394571C1 (ru) | 2009-05-14 | 2010-07-20 | Государственное бюджетное учреждение здравоохранения города Москвы "Городская клиническая больница № 24" Департамента здравоохранения города Москвы | Способ лечения воспалительных заболеваний кишечника |
| RU2418586C2 (ru) | 2009-06-11 | 2011-05-20 | Государственное образовательное учреждение высшего профессионального образования "Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО НГМУ Росздрава) | Способ коррекции нарушений в репродуктивных органах, вызванных высокой температурой |
| RU2428183C1 (ru) | 2010-07-01 | 2011-09-10 | Рина Михайловна Заславская | Адаптоген для метеочувствительных больных стенокардией и артериальной гипертензией и применение мелатонина в качестве адаптогена |
-
2012
- 2012-05-24 RU RU2012121410/15A patent/RU2488388C1/ru not_active IP Right Cessation
- 2012-10-31 UA UAA201412436A patent/UA112352C2/uk unknown
- 2012-10-31 WO PCT/RU2012/000888 patent/WO2013176567A1/ru active Application Filing
- 2012-10-31 JP JP2015513964A patent/JP5864819B2/ja not_active Expired - Fee Related
- 2012-10-31 KR KR1020147032836A patent/KR101581611B1/ko not_active Ceased
- 2012-10-31 EA EA201400973A patent/EA201400973A1/ru unknown
- 2012-10-31 US US14/400,526 patent/US20150157604A1/en not_active Abandoned
- 2012-10-31 CA CA2873891A patent/CA2873891C/en not_active Expired - Fee Related
- 2012-10-31 IN IN9940DEN2014 patent/IN2014DN09940A/en unknown
- 2012-10-31 AU AU2012380583A patent/AU2012380583B2/en not_active Revoked
- 2012-10-31 HK HK15106114.1A patent/HK1205467A1/xx unknown
- 2012-10-31 EP EP12877152.4A patent/EP2857011A4/en not_active Withdrawn
- 2012-10-31 CN CN201280073167.XA patent/CN104334166A/zh not_active Withdrawn
-
2014
- 2014-11-23 IL IL235852A patent/IL235852A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA112352C2 (uk) | 2016-08-25 |
| AU2012380583A1 (en) | 2014-12-18 |
| CN104334166A (zh) | 2015-02-04 |
| JP5864819B2 (ja) | 2016-02-17 |
| JP2015517569A (ja) | 2015-06-22 |
| RU2488388C1 (ru) | 2013-07-27 |
| US20150157604A1 (en) | 2015-06-11 |
| KR101581611B1 (ko) | 2015-12-31 |
| IL235852A0 (en) | 2015-01-29 |
| CA2873891A1 (en) | 2013-11-28 |
| EP2857011A1 (en) | 2015-04-08 |
| EP2857011A4 (en) | 2015-12-02 |
| EA201400973A1 (ru) | 2015-02-27 |
| WO2013176567A1 (ru) | 2013-11-28 |
| KR20150005999A (ko) | 2015-01-15 |
| AU2012380583B2 (en) | 2015-01-22 |
| CA2873891C (en) | 2016-02-16 |
| HK1205467A1 (en) | 2015-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN09940A (enEXAMPLES) | ||
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| PH12016500094A1 (en) | Autotaxin inhibitors | |
| PT3674298T (pt) | Indazóis substituídos, métodos para a sua produção, preparações farmacêuticas que contêm os mesmos e sua utilização para produção de medicamentos | |
| GB201106743D0 (en) | Novel compounds | |
| IN2015DN03998A (enEXAMPLES) | ||
| IL233602A (en) | The history of benzamide, their preparation and their pharmaceutical preparations | |
| UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| IN2013MU03918A (enEXAMPLES) | ||
| PH12017500348A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| MX2020009444A (es) | Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion. | |
| IN2014DN10449A (enEXAMPLES) | ||
| MX2017015137A (es) | Composicion farmaceutica oral de dosis diaria de isotretinoin. | |
| HUP1300647A2 (hu) | Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik | |
| IL237688A0 (en) | A syringe containing a preparation, in particular a pharmaceutical preparation containing immunoglobulins, a method for its production and use | |
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
| MD4615B1 (ro) | Formă solidă izolată de monoclorhidrat de anamorelin, compoziţie farmaceutică şi procedeu de fabricare a formei de dozare farmaceutice care o conţine | |
| WO2015044434A3 (de) | FLUOR-9-METHYL-ß-CARBOLINE | |
| AP2012006308A0 (en) | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them. | |
| IN2014MN01492A (enEXAMPLES) | ||
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| IN2013MU03317A (enEXAMPLES) | ||
| IN2014DN07897A (enEXAMPLES) | ||
| IN2015MN00091A (enEXAMPLES) |